Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?

Clinical Rheumatology

Volumn 28, Issue 2, 2009, Pages 241-242

  Carlo Stella, Nicoletta ^a   Belloli, Laura ^a   Biondi, Maria Luisa ^b   Marasini, Bianca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; HYPOXIA; IMMUNOASSAY; LETTER; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 58149178592     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1048-0     Document Type: Letter

References (8)

1. Choi HJ, Shin YK, Hyun JL et al (2008) The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients. Clin Rheumatol 27:437-442
2. Subcomittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
3. Clements PJ, Meedsger TA Jr, Feghali CA (2004) Cutaneous involvement in systemic sclerosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis, 2nd edn. Lippincott Williams and Wilkins, Baltimore, pp 129-150
4. Lip P, Wang D, Lucas J et al (2008) Atrial natriuretic peptide inhibits Transforming Growth Factor β-induces Smad signalling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102:185-192
5. Goetze JP, Christoffersen C, Perko M et al (2003) Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17:1105-1107
6. Casco VH, Veinot JP, Kuroski de Bold ML et al (2002) Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 50:799-809
7. Hopkins WE, Chen Z, Fukagawa NK et al (2004) Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109:2872-2877
8. Clements PJ, Hurwitz EL, Wong WK et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial. Arthritis Rheum 43:2445-2454